CoChat

Endometriosis and nuclear receptors

Open access
Yilmaz, Bahar D, Bulun, Serdar E · 2019 · Human Reproduction Update

The DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index; 46 of the 107 sources its claims cite were checked for support.

Abstract

BACKGROUND: Endometriosis is recognized as a steroid-dependent disorder; however, the precise roles of nuclear receptors (NRs) in steroid responsiveness and other signaling pathways are not well understood. OBJECTIVE AND RATIONALE: Over the past several years, a number of paradigm-shifting breakthroughs have occurred in the area of NRs in endometriosis. We review and clarify new information regarding the mechanisms responsible for: (i) excessive estrogen biosynthesis, (ii) estrogen-dependent inflammation, (iii) defective differentiation due to progesterone resistance and (iv) enhanced survival due to deficient retinoid production and action in endometriosis. We emphasize the roles of the relevant NRs critical for these pathological processes in endometriosis. SEARCH METHODS: We conducted a comprehensive search using PubMed for human, animal and cellular studies published until 2018 in the following areas: endometriosis; the steroid and orphan NRs, estrogen receptors alpha (ESR1) and beta (ESR2), progesterone receptor (PGR), steroidogenic factor-1 (NR5A1) and chicken ovalbumin upstream promoter-transcription factor II (NR2F2); and retinoids. OUTCOMES: Four distinct abnormalities in the intracavitary endometrium and extra-uterine endometriotic tissue underlie endometriosis progression: dysregulated differentiation of endometrial mesenchymal cells, abnormal epigenetic marks, inflammation activated by excess estrogen and the development of progesterone resistance. Endometriotic stromal cells compose the bulk of the lesions and demonstrate widespread epigenetic abnormalities. Endometriotic stromal cells also display a wide range of abnormal NR expression. The orphan NRs NR5A1 and NR2F2 compete to regulate steroid-synthesizing genes in endometriotic stromal cells; NR5A1 dominance gives rise to excessive estrogen formation. Endometriotic stromal cells show an abnormally low ESR1:ESR2 ratio due to excessive levels of ESR2, which mediates an estrogen-driven inflammatory process and prostaglandin formation. These cells are also deficient in PGR, leading to progesterone resistance and defective retinoid synthesis. The pattern of NR expression, involving low ESR1 and PGR and high ESR2, is reminiscent of uterine leiomyoma stem cells. This led us to speculate that endometriotic stromal cells may display stem cell characteristics found in other uterine tissues. The biologic consequences of these abnormalities in endometriotic tissue include intense inflammation, defective differentiation and enhanced survival. WIDER IMPLICATIONS: Steroid- and other NR-related abnormalities exert genome-wide biologic effects via interaction with defective epigenetic programming and enhance inflammation in endometriotic stromal cells. New synthetic ligands, targeting PGR, retinoic acid receptors and ESR2, may offer novel treatment options.

Overview

CoChat Summary

TL;DR

This review synthesizes evidence that nuclear receptors—especially NR5A1, NR2F2, ESR1/ESR2, PGR, and retinoid receptors—drive endometriosis through excessive local estrogen synthesis, estrogen-dependent inflammation, progesterone resistance, and deficient retinoid action. It highlights epigenetic abnormalities in endometriotic stromal cells and stem-cell-like populations as central mechanisms and discusses emerging receptor-targeted therapies.

Key findings

  • NR5A1 mRNA is ~12,000-fold higher in endometriosis than in eutopic endometrium; NR5A1 binds promoters of StAR, CYP11A1, HSD3B2, CYP17A1, and aromatase, and competes with NR2F2 to activate steroidogenic genes in endometriotic stromal cells.
  • ESR2 RNA is 40- to 140-fold higher in stromal cells from ovarian endometriomas than in healthy eutopic endometrial stromal cells; the ESR2:ESR1 mRNA ratio reaches an ~800-fold difference, while ESR1 mRNA is ~7-fold lower.
  • Progesterone resistance involves very low PGR-A and undetectable PGR-B in peritoneal endometriotic lesions, with PGR-B promoter hypermethylation and microRNA-mediated PGR downregulation (e.g., miR-194-3p, miR-196a, miR-29c).
  • Retinoid deficiency in endometriotic stromal cells includes downregulated STRA6, deficient RBP1, higher CYP26B1, and a decreased CRABP2:FABP5 ratio, favoring FABP5/PPAR-β/δ-mediated survival and reduced HSD17B2-dependent estradiol inactivation.

Methods

  • Comprehensive PubMed search for English-language human, animal, and cellular studies published until June 2018, using keywords including endometriosis, ESR1, ESR2, PGR, NR5A1, NR2F2, RAR, and endometrial stem cells.
  • Narrative review and synthesis of the literature on nuclear receptors in endometriosis pathogenesis, progression, and therapeutic targeting; no formal meta-analysis or quantitative pooling is described.

Limitations

  • The paper states that no germ-line or causative somatic mutations have been reported in endometriosis, that the relationship between DNMT expression and ESR2 promoter hypomethylation remains to be discovered, that long-term efficacy of SPRMs remains to be proven, and that future preclinical studies are required for ESR2-targeting agents.
  • Evident from the text: this is a narrative review with a PubMed search limited to June 2018, relying heavily on animal and cell-culture models; it reports inconsistent polymorphism associations and does not perform a systematic risk-of-bias assessment or quantitative synthesis.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/humupd/dmz005

Cites

191 of 191 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

37 Valid · 3 Not valid · 40 Not checked · 31 Own results and interpretations

55 more claims · 18 with their cited sources checked

Create a free account to see all 111 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 38
  • Probably not a substantial claim. 18

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 191 references

Cited by

See all 243

Metadata

Authors
Yilmaz, B. D., & Bulun, S. E.
Affiliations
Northwestern University (US)
Corresponding author
Bulun, Serdar E
Venue
Human Reproduction Update
Published
2019-02-27
Volume
25
Issue
4
Pages
473-485
ISSN
  • 1355-4786 (ISSN-L)
  • 1460-2369
OpenAlex
W2915590567
Cited by
243
References
191
Citations by year
2026: 26 · 2025: 27 · 2024: 50 · 2023: 42 · 2022: 30 · 2021: 33 · 2020: 27 · 2019: 7
FWCI
3.41
Type
journal article
Language
en
Open access
Locations
  • Human Reproduction Update (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • NIH (R37-HD38691)
  • Vehbi Koc Foundation
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords
endometriosis, nuclear receptors, estrogen receptor, ESR1, ESR2, progesterone receptor, steroidogenic factor 1, NR2F2, retinoids, estrogen synthesis, progesterone resistance, endometrial differentiation, epigenetic abnormalities, endometriotic stromal cells, stem cell properties
MeSH terms
Animals, Endometriosis, Estrogens, Female, Hormone Antagonists, Hormones, Humans, Ligands, Progesterone, Signal Transduction, Receptors, Cytoplasmic and Nuclear

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Endometriosis and nuclear receptors. https://app.cochat.ai/papers/10.1093/humupd/dmz005
The paper
Yilmaz, B. D., & Bulun, S. E. (2019). Endometriosis and nuclear receptors. Human Reproduction Update. https://doi.org/10.1093/humupd/dmz005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.